Aptevo Therapeutics Inc. Business Operations Contracts & Agreements
15 Contracts & Agreements
- Advisory Agreements (1 contract)
- Agency Agreements (5)
- Collaboration Agreements (6)
- Services Agreements (2)
- Supply Agreements (1)
- Placement Agency Agreement, dated September 16, 2024, between the Company and Roth Capital Partners (Filed With SEC on September 18, 2024)
- PLACEMENT AGENCY AGREEMENT (Filed With SEC on August 30, 2024)
- Placement Agency Agreement dated June 28, 2024, between the Company and Roth Capital Partners (Filed With SEC on July 1, 2024)
- Form of Placement Agency Agreement (Filed With SEC on June 14, 2024)
- Form of Placement Agency Agreement (Filed With SEC on March 20, 2024)
- Financial Advisory Agreement, dated as of November 9, 2023, between A.G.P./Alliance Global Partners and the Company (Filed With SEC on November 9, 2023)
- Amendment No. 4 to the Collaboration and License Agreement dated as of December 19, 2005 (as previously amended, the Agreement) by and between Emergent Product Development... (Filed With SEC on August 14, 2020)
- Amendment No. 3 to the Collaboration and License Agreement dated as of December 19, 2005 (as previously amended, the Agreement) by and between Emergent Product Development... (Filed With SEC on August 14, 2020)
- Amendment No. 2 to the Collaboration and License Agreement dated as of December 19, 2005 (as previously amended, the Agreement) by and between Trubion Pharmaceuticals, Inc.... (Filed With SEC on August 14, 2020)
- Amendment No. 1 to the Collaboration and License Agreement dated as of December 19, 2005 (the Agreement) by and between Trubion Pharmaceuticals, Inc. (Trubion) and Wyeth, acting... (Filed With SEC on August 14, 2020)
- Collaboration and License Agreement, dated as of December 19, 2005, by and among Wyeth Pharmaceuticals and Trubion Pharmaceuticals, Inc (Filed With SEC on August 14, 2020)
- Amended and Restated Manufacturing Services Agreement, dated September 28, 2017, by and between Emergent BioSolutions Inc. and Aptevo Therapeutics Inc (Filed With SEC on March 13, 2018)
- Collaboration and Option Agreement, dated as of July 20, 2017, by and between Aptevo Research and Development LLC, and Alligator Bioscience AB (Filed With SEC on November 13, 2017)
- Amended and Restated COMMERCIAL SUPPLY AGREEMENT BETWEEN CMC ICOS BIOLOGICS, INC. and APTEVO BIOTHERAPEUTICS LLC. DISCLAIMER THIS DOCUMENT IS ISSUED BY CMC FOR DISCUSSION PURPOSES... (Filed With SEC on August 10, 2017)
- MANUFACTURING SERVICES AGREEMENT BY AND BETWEEN EMERGENT BIOSOLUTIONS INC. AND APTEVO THERAPEUTICS INC. DATED AS OF JULY 29, 2016 TABLE OF CONTENTS (Filed With SEC on August 2, 2016)
